Handl Health
PrivateLast Round
Series A
Feb 23, 2026
Total Funding Raised
$18.69M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Handl Health operates in Healthcare & Life Sciences and is based in Culver City, California. Its latest recorded funding round was a Series A round in February 2026.
Handl Health is a healthcare financial technology company that provides an AI-powered platform to aggregate and analyze healthcare pricing data for benefits consultants, carriers, and third-party administrators.
Sector
Healthcare & Life Sciences
Verticals
InsurTech, Healthcare Analytics, Vertical SaaS
Business Model
B2B2C
Customer Profile
Subscription SaaS, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Handl Health Comparables
Compare Handl Health with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Flume Health | 86% | |
| Comprehensive Healthcare Systems Inc. | 73% | |
| MacroHealth | 70% |
For institutional investors. Book with your work email.
Handl Health Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Feb 23, 2026 | ||||
| Grant | Apr 24, 2024 | ||||
| Seed | Apr 24, 2024 | ||||
| Accelerator | Mar 13, 2023 | ||||
| Accelerator | Nov 29, 2022 | ||||
Grant | Sep 21, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Handl Health Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Arthur Ventures | Series A |
| Plug and Play Tech Center | Seed |
| Techstars | Seed, Accelerator |
| Everywhere Ventures | Seed |
| Boutique Venture Partners | Seed, Series A |
| National Institute of Nursing Research | Grant |
| Riverfront Ventures | Seed, Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 24, 2026
Grew 21% QoQ from 28 to 34 employees.
- Aug 20, 2026
Monthly visitors grew 95% MoM.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- hiresAug 11, 2026
Handl Health hires Justin Cross as senior vice president of employer solutions in a newly created role in California on Aug 11th '26.
For institutional investors. Book with your work email.
Handl Health Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Handl Health's valuation, stock price, and market status.
Is Handl Health a public or private company?
Handl Health is a private company.
What is the current stock price of Handl Health?
Handl Health is a private company, so its shares have no public market price. Caplight tracks Handl Health's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Handl Health worth (valuation)?
Valuation information for Handl Health is not publicly available.
Can I buy Handl Health stock?
Handl Health shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Handl Health's last funding round?
Handl Health's most recent funding round was Series A on February 23, 2026.
Who are the main investors in Handl Health?
Key investors in Handl Health include Arthur Ventures, Techstars, Everywhere Ventures, Mucker Capital.
Will Handl Health IPO soon?
No public IPO plans have been announced for Handl Health.
How can I track Handl Health secondary market activity?
Caplight tracks bids, offers, and trades in Handl Health's shares on secondary markets.